These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7436771)

  • 1. Chronic renal failure management-Part I.
    Nickas GM
    Ariz Med; 1980 Sep; 37(9):637-8. PubMed ID: 7436771
    [No Abstract]   [Full Text] [Related]  

  • 2. [Adynamic bone disease in kidney failure. Role of aluminum].
    Cohen-Solal ME; Sebert JL; Morinière P; Fournier A
    Rev Rhum Ed Fr; 1993 May; 60(5):361-4. PubMed ID: 8167643
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bone disease in patients with chronic renal insufficiency--on the problem of early diagnosis (author's transl)].
    Sotorník I; Dráb K; Slíz K; Bláha J; Vavrejn B; Ondrácek P
    Cas Lek Cesk; 1980; 119(11):325-9. PubMed ID: 7397719
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cardiovascular disorders in chronic renal failure].
    Bagriĭ AE
    Ter Arkh; 1998; 70(11):80-3. PubMed ID: 9949472
    [No Abstract]   [Full Text] [Related]  

  • 5. Controlling the epidemic of cardiovascular disease in chronic renal disease: report from the National Kidney Foundation Task Force on cardiovascular disease.
    Meyer KB; Levey AS
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S31-42. PubMed ID: 11443766
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of cardiovascular risk during substitution management: silent cardiopathies].
    Machecourt J
    Nephrologie; 2000; 21(7):351-2. PubMed ID: 11200609
    [No Abstract]   [Full Text] [Related]  

  • 7. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to know? Where do we go from here? Special report from the National Kidney Foundation Task Force on Cardiovascular Disease.
    Am J Kidney Dis; 1998 Nov; 32(5 Suppl 3):S1-199. PubMed ID: 9867706
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder.
    Fukagawa M; Yokoyama K; Koiwa F; Taniguchi M; Shoji T; Kazama JJ; Komaba H; Ando R; Kakuta T; Fujii H; Nakayama M; Shibagaki Y; Fukumoto S; Fujii N; Hattori M; Ashida A; Iseki K; Shigematsu T; Tsukamoto Y; Tsubakihara Y; Tomo T; Hirakata H; Akizawa T; ;
    Ther Apher Dial; 2013 Jun; 17(3):247-88. PubMed ID: 23735142
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hyperhomocysteinemia in chronic renal failure].
    Sydor A; Sułowicz W
    Przegl Lek; 1999; 56(7-8):520-4. PubMed ID: 10575921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral density in end-stage renal disease patients: association with wasting, cardiovascular disease and mortality.
    Matsubara K; Suliman ME; Qureshi AR; Axelsson J; Martola L; Heimbürger O; Barany P; Stenvinkel P; Lindholm B
    Blood Purif; 2008; 26(3):284-90. PubMed ID: 18421213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiovascular system function in patients with chronic kidney failure on hemodialysis].
    Rzhevskaia ON; Danilkov AP
    Urol Nefrol (Mosk); 1997; (2):45-51. PubMed ID: 9206884
    [No Abstract]   [Full Text] [Related]  

  • 12. The spectrum of renal bone disease: introduction.
    LeBoff MS
    Semin Nephrol; 2009 Mar; 29(2):95-6. PubMed ID: 19371799
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical practice guidelines for bone metabolism and disease in chronic kidney disease: an overview.
    Bailie GR; Massry SG;
    Pharmacotherapy; 2005 Dec; 25(12):1687-707. PubMed ID: 16305288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contributions of the software La Clé Concerto in the implementation of the NKF-K/DOQI (National Kidney Foundation-Kidney/Dialysis Outcomes Quality Initiative) recommendations for the control of mineral and bone metabolism disorders in the patient with chronic renal failure].
    Ureña P
    Nephrol Ther; 2008 Sep; 4 Spec No 1():9-14, 20-35. PubMed ID: 19031633
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic kidney disease as a cardiovascular risk factor.
    Best PJ; Holmes DR
    Am Heart J; 2003 Mar; 145(3):383-6. PubMed ID: 12660658
    [No Abstract]   [Full Text] [Related]  

  • 16. [Renal osteopathies. Essentials of their aetiology, diagnosis, and treatment (author's transl)].
    Kocián J; Sotorník I
    Cas Lek Cesk; 1981 Aug; 120(31-32):941-4. PubMed ID: 7261018
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic kidney disease-related mineral and bone disorders.
    Argilés A; Vanholder R
    Nephron Clin Pract; 2009; 112(3):c128-36. PubMed ID: 19390213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of chronic kidney disease-mineral bone disorder.
    Ruf KM; Clifford T
    Orthopedics; 2010 Feb; 33(2):98-101. PubMed ID: 20187588
    [No Abstract]   [Full Text] [Related]  

  • 19. Anemia in predialysis chronic renal failure: what are we treating?
    Foley RN; Parfrey PS
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S82-4. PubMed ID: 11443774
    [No Abstract]   [Full Text] [Related]  

  • 20. Contribution of bone and mineral abnormalities to cardiovascular disease in patients with chronic kidney disease.
    Raggi P; Kleerekoper M
    Clin J Am Soc Nephrol; 2008 May; 3(3):836-43. PubMed ID: 18322050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.